
Big Pharma ad spending edges toward $7B with Sanofi, Regeneron and Novo Nordisk leading the way
Drugmakers spent close to $7 billion on consumer advertising in 2021. The exact final US media tally – $6.88 billion – is up just slightly from the $6.86 billion spent in 2020, according to Kantar’s media tracking data.
Topping the list of drug spending brands is a new leader for the first time in years. Sanofi and Regeneron’s multi-indication asthma and eczema med Dupixent took the top spot from AbbVie’s perennial big spender brand Humira which has been No. 1 since 2015. AbbVie, facing Humira generic competition next year, has taken its foot off the gas and redistributed spending to other brands including Skyrizi and Rinvoq.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,600+ biopharma pros reading Endpoints daily — and it's free.